MedTrace Logo

Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%

NCT00595543 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 166

Last updated 2009-03-19

No results posted yet for this study

Summary

To compare bromfenac 0.09%, diclofenac sodium 0.1%, and ketorolac tromethamine 0.5% ophthalmic solutions for the treatment of acute pseudophakic CME after cataract surgery.

Conditions

  • Acute Pseudophakic Cystoid Macular Edema

Interventions

DRUG

Bromfenac

1 drop (in the eye) Instill one drop in the affected eye twice daily for three months

DRUG

Ketorolac

1 drop (in the eye) Instill one drop in the affected eye four times daily for three months

DRUG

Diclofenac

1 drop (in the eye) Instill one drop in the affected eye four times daily for three months

Sponsors & Collaborators

  • Bp Consulting, Inc

    lead NETWORK

Principal Investigators

  • David Rho, MD · Soll Eye Associates

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00595543 on ClinicalTrials.gov